17 results  1 of 1 

1 Osimertinib Combined with Systemic Chemotherapy for EGFR Mutant, T790M-Negative, Non–Small Cell Lung Cancer Patients Who Develop Leptomeningeal Metastases with Extracranial Progression to Prior EGFR TKI
Hye Ryeon Kim, Hyunji Jo, Hongsik Kim, Joohyun Hong, Sehhoon Park, Hyun Ae Jung, Se-Hoon Lee, Jin-Seok Ahn, Myung-Ju Ahn
Cancer Res Treat.2023;55(1):344-349.   Published online 2022 March 26     DOI: http://dx.doi.org/10.4143/crt.2021.1603
      
2 Methionyl-tRNA Synthetase is a Useful Diagnostic Marker for Lymph Node Metastasis in Non-Small Cell Lung Cancer
Jung Mo Lee, Taehee Kim, Eun Young Kim, Arum Kim, Dong Ki Lee, Nam Hoon Kwon, Sunghoon Kim, Yoon Soo Chang
Yonsei Med J.2019;60(11):1005-1012.   Published online 2019 October 17     DOI: http://dx.doi.org/10.3349/ymj.2019.60.11.1005
      
3 Immunotherapy for Non-small-cell Lung Cancer: Current Status and Future Obstacles
Ju Hwan Cho
Immune Netw.2017;17(6):378-391.   Published online 2017 November 24     DOI: http://dx.doi.org/10.4110/in.2017.17.6.378
      
4 Evolving Cancer Classification in the Era of Personalized Medicine: A Primer for Radiologists
Ailbhe C. O'Neill, Jyothi P. Jagannathan, Nikhil H. Ramaiya
Korean J Radiol.2017;18(1):6-17.   Published online 2017 January 5     DOI: http://dx.doi.org/10.3348/kjr.2017.18.1.6
      
5 The effects of adjuvant therapy and prognostic factors in completely resected stage IIIa non-small cell lung cancer
Se Haeng Cho, Kyung Young Chung, Joo Hang Kim, Byung Soo Kim, Joon Chang, Sung Kyu Kim, Won Young Lee
Tuberc Respir Dis.1996;43(5):709-719.   Published online 2016 March 15     DOI: http://dx.doi.org/10.4046/trd.1996.43.5.709
      
6 Loss of Heterozygosity at 3p in Korean Non-Small Cell Lung Cancer
Choon Taek Lee, Mi Hee Kim, Kyung Ho Park, Jong Ho Park, Hee Jong Baek, Jae Ill Zo, Jin Kyoo Kim, Chang Min Kim
Tuberc Respir Dis.1998;45(5):975-983.   Published online 2016 March 14     DOI: http://dx.doi.org/10.4046/trd.1998.45.5.975
      
7 Immunohistochemical Staining of Insulin-like Growth Factor-1 in Human Lung Cancer cells of NSCLC and SCLC
Ji Hyun Park, Myoung Jae Kang, Heung Bum Lee, Yong Chul Lee, Yang Keun Rhee
Tuberc Respir Dis.2000;48(3):324-330.   Published online 2016 March 11     DOI: http://dx.doi.org/10.4046/trd.2000.48.3.324
      
8 Influence of cathepsin D expression on prognosis in non-small cell lung cancer
Hyung Roul Youm, Jae Il Myeong, Jong Chul Lim, Han Kyun Kim, Nam Hun Lee, Dae Ho Lee, Hyang Mee Ko, Jong Yeoung Moon, Heon Seok Kang, Heong Seon Rheu, Wan Kim, Chang Soo Park, Kyung Ok Park
Tuberc Respir Dis.2000;49(1):60-71.   Published online 2016 March 11     DOI: http://dx.doi.org/10.4046/trd.2000.49.1.60
      
9 Causes of Unresectability in Non-Small Cell Lung Cancer Patients Thought to Be Resectable Preoperatively
Yeon Mok Oh, Eun Kyung Mo, Man Pyo Jung, Chul Gyu Yoo, Young Whan Kim, Sung Koo Han, Young Soo Sim, Keun Youl Kim, Yong Chol Han
Tuberc Respir Dis.1994;41(2):97-102.   Published online 2016 February 1     DOI: http://dx.doi.org/10.4046/trd.1994.41.2.97
      
10 Role of Loss of O6-Methylguanine DNA Methyltransferase (MGMT) Expression in Non-Small Cell Lung Carcinomas (NSCLCs): with Reference to the Relationship with p53 Overexpression
Na-Hye Myong
Cancer Res Treat.2010;42(2):95-100.   Published online 2010 June 30     DOI: http://dx.doi.org/10.4143/crt.2010.42.2.95
      
11 Targeted Therapy of Lung Cancer
Kye Young Lee
J Korean Med Assoc.2008;51(5):483-491.   Published online 2008 May 31     DOI: http://dx.doi.org/10.5124/jkma.2008.51.5.483
      
12 Immunohistochemical Analysis for the Expression of DR5 TRAIL Receptor and p53 in Non-small Cell Lung Cancer
Kye-Young Lee, Jung-Hyun Lee, Sun-Jong Kim, Kwang-Ha Yoo
Tuberc Respir Dis.2008;64(4):278-284.   Published online 2008 April 30     DOI: http://dx.doi.org/10.4046/trd.2008.64.4.278
      
13 High Frequency of Genetic Alterations in Non-small Cell Lung Cancer Detected by Multi-target Fluorescence In Situ Hybridization
Ji Un Kang, Sun Hoe Koo, Kye Chul Kwon, Jong Woo Park, So Youn Shin, Jin Man Kim, Sung Su Jung
J Korean Med Sci.2007;22(Suppl):S47-S51.   Published online 2007 September 30     DOI: http://dx.doi.org/10.3346/jkms.2007.22.S.S47
      
14 Promoter -202 A/C Polymorphism of Insulin-like Growth Factor Binding Protein-3 Gene and Non-small Cell Lung Cancer Risk
Jin Wook Moon, Yoon Soo Chang, Chang Hoon Han, Shin Myung Kang, Moo Suk Park, Min Kwang Byun, Wou Young Chung, Jae Jun Park, Kyeong Nam Yoo, Ju Hye Shin, Young Sam Kim, Joon Chang, Sung Kyu Kim, Hee Jung Kim, Se Kyu Kim
Tuberc Respir Dis.2005;58(4):359-366.   Published online 2005 April 30     DOI: http://dx.doi.org/10.4046/trd.2005.58.4.359
      
15 Multimodality Treatement in Patients with Clinical Stage IIIA NSCLC
Yun Seun Lee, Pil Soon Jang, Hyun Mo kang, Jeung Eyun Lee, Sun Jung Kwon, Jin Yong An, Sung Soo Jung, Ju Ock Kim, Sun Young Kim
Tuberc Respir Dis.2004;57(6):557-566.   Published online 2004 December 31     DOI: http://dx.doi.org/10.4046/trd.2004.57.6.557
      
16 Concurrent Chemoradiation with Weekly Paclitaxel in Locally Advanced Non-small Cell Lung Cancer
Kang Woo Bae, Tak Ho Song, Joo Yeon Yang, Yun Seup Kim, Jae Seok Park, Young Koo Jee, Kye Young Lee
Tuberc Respir Dis.2004;57(4):351-357.   Published online 2004 October 31     DOI: http://dx.doi.org/10.4046/trd.2004.57.4.351
      
17 The Expression of MUC1 and CD44s in Non-small Cell Lung Cancer
Hye Kyung Park, Ji Seok Lee, Jun Hee Lee, Jung Wook Lee, Yun Seong Kim, Min Ki Lee, Young Dae Kim, Hyung Ryul Lee, Kun Il Kim, Cang Hun Lee, Soon Kew Park
Tuberc Respir Dis.2002;52(2):117-127.   Published online 2002 February 28     DOI: http://dx.doi.org/10.4046/trd.2002.52.2.117
      

 1 of 1